We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Robotic Guidance Arm Assists Knee Replacement Surgery

By HospiMedica International staff writers
Posted on 26 Feb 2013
A new robotic guidance arm helps surgeons precisely place an implant in unicompartmental knee surgery, also known as partial knee resurfacing. More...


The Sculptor Robotic Guidance Arm (RGA) assists the surgeon's operation of a cutting burr, limiting the procedure to a safe area so that bone is only removed corresponding to the implant's planned position, as determined both pre- and intraoperatively. A second mechanical tracking arm is attached to the bone that is being sculpted to accurately track the location of the patient, providing real time dynamic referencing relative to both the position of the robotic arm and the surgical plan. The surgeon-controlled system includes an interactive touch screen used throughout the procedure.

The system is based on patent-protected Active Constraint technology, which essentially creates a safety perimeter around the knee, beyond which the cutting tool is not allowed to travel, defining an actual volume of space within which the burr can be used. The robotic arm can consistently and accurately enable the positioning of a prosthetic implant according to a surgical plan within 2° of the desired orientation, versus 40% for conventionally implanted prosthetics.

By combining Sculptor RGA technology with patient specific partial knee implants, surgeons can provide a bone conserving solution that is personalized for each case, is affordable, and offers clinical benefits and cost effectiveness when compared current treatment options such as saws and jigs, which are prone to a much higher degree of placement error. The Sculptor (RGA) system is a product of Stanmore Implants (Borehamwood, United Kingdom), and has been approved by the US Food and Drug Administration (FDA).

“Robotic technology represents a major advance in orthopedics, providing accurate placement that is critical to implant longevity and reproducibility along with tangible cost benefits, making access to robotic surgery more widely available to patients,” said Brian Steer, Executive Chairman of Stanmore Implants. “Stanmore is now looking forward to working further with surgeons to continue to develop innovative solutions for the global orthopedic market.”

Related Links:
Stanmore Implants


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.